The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study

Fingolimod approval was based mainly on two clinical trials, FREEDOMS and TRANSFORMS, which demonstrated the efficacy and safety of fingolimod in patients with multiple sclerosis (MS). We present an observational study that validates these trials findings in a real-world setting, whereby the effecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Izquierdo, Guillermo, Damas, Fátima, Páramo, Maria Dolores, Ruiz-Peña, Juan Luis, Navarro, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409154/
https://www.ncbi.nlm.nih.gov/pubmed/28453541
http://dx.doi.org/10.1371/journal.pone.0176174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409154/
https://www.ncbi.nlm.nih.gov/pubmed/28453541
http://dx.doi.org/10.1371/journal.pone.0176174

Ejemplares similares